This review summarizes the current landscape of ADC development, focusing on target selection and adverse impacts. It will guide future research to optimize the efficacy and safety of ADCs. ADCs are a ...
The advent and proliferation of targeted modalities represent an evolutionary leap forward in drug development. By binding ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Astellas Pharma already has the first FDA approval for a therapy that goes after Claudin 18.2, a protein whose overexpression on the surface of cells in gastrointestinal cancers makes it an attractive ...
The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback